Abstract
In order to verify whether neurofibromatosis type 2 (NF2) could influence the oncological and functional outcome in large vestibular schwannoma (VS) surgery, we compared a group of NF2 patients operated with a facial nerve-sparing technique to a group of sporadic VSs of similar volume that underwent the same treatment regimen in the same period. Single-center retrospective cohort study about 12 consecutive NF2 and 69 non-NF2 patients operated on for large VS between September 2006 and November 2016. After resection, patients were allocated to an upfront Gamma Knife surgery policy of the tumor residue. At last follow-up examination, the facial nerve function was good (House-Brackmann grades I or II) in 92% of the NF2 and 83% of the non-NF2 patients (p = .90). The median volume of tumor residue was .92 cc in the NF2 group and .54 cc in the non-NF2 group (p = .14). Tumor control was achieved in 83% and 81% of cases in the NF2 and the non-NF2 populations, respectively, with a mean follow-up of 73 months in both groups. The 1-, 5-, and 7-year progression-free survival were 92%, 83%, and 83% respectively in the NF2 group, and 99%, 83%, and 80% in the non-NF2 group (p = .96). Our analysis of 12 NF2 and 69 non-NF2 patients operated on by the same surgical team with the same treatment regimen did not show any functional or tumor control difference between those groups.
Similar content being viewed by others
References
Baser ME, Makariou EV, Parry DM (2002) Predictors of vestibular schwannoma growth in patients with neurofibromatosis type 2. J Neurosurg 96:217–222
Chen Z, Prasad SC, Di Lella F et al (2014) The behavior of residual tumors and facial nerve outcomes after incomplete excision of vestibular schwannomas. J Neurosurg 120(6):1278–1287
Di Nardo W, Fetoni A, Buldrini S, Di Girolamo S (2001) Auditory brainstem and cochlear implants: functional results obtained after one year of rehabilitation. Eur Arch Otorhinolaryngol 258(1):5–8
Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP, Lonser RR, Asthagiri AR (2012) Long-term natural history of neurofibromatosis type 2-associated intracranial tumors. J Neurosurg 117:109–117
Dobel C, Miltner WH, Witte OW et al (2013) Emotional impact of facial palsy. Laryngorhinootologie 92:9–23
Gardner G, Robertson JH (1998) Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 97:55–66
Haque R, Wojtasiewicz TJ, Gigante PR et al (2011) Efficacy of facial-sparing approach in patients with vestibular schwannomas. J Neurosurg 115:917–923
House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147
Iwai Y, Ishibashi K, Watanabe Y, Uemura G, Yamanaka K (2015) Functional preservation after planned partial resection followed by gamma knife radiosurgery for large vestibular schwannomas. World Neurosurg 84(2):292–300
Iwai Y, Yamanaka K, Ishiquro T (2003) Surgery combined with radiosurgery of large acoustic neuromas. Surg Neurol 59(4):283–289
Jeltema HR, Bakker NA, Bijl HP, Wagemakers M, Metzemaekers JDM, van Dijk JMC (2015) Near total extirpation of vestibular schwannoma with salvage radiosurgery. Laryngoscope 125(7):1703–1707
Koos WT, Day JD, Matula C, Levy DI (1998) Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg 88:506–512
Lee J, Fung K, Lownie SP, Parnes LS (2007) Assessing impairment and disability of facial paralysis in patients with vestibular schwannoma. Arch Otolaryngol Head Neck Surg 133:56–60
Matthies C, Brill S, Varallyay C, Solymosi L, Gelbrich G, Roosen K, Ernestus RI, Helms J, Hagen R, Mlynski R, Shehata-Dieler W, Müller J (2014) Auditory brainstem implants in neurofibromatosis type 2: is open speech perception feasible? J Neurosurg 120(2):546–558
Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L (2002) Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study. J Neurosurg 96:223–228
Monfared A, Corrales CE, Theodosopoulos PV, Blevins NH, Oghalai JS, Selesnick SH, Lee H, Gurgel RK, Hansen MR, Nelson RF, Gantz BJ, Kutz JW Jr, Isaacson B, Roland PS, Amdur R, Jackler RK (2016) Facial nerve outcome and tumor control rate as a function of degree of resection in treatment of large acoustic neuromas: preliminary report of the Acoustic Neuroma Subtotal Resection Study (ANSRS). Neurosurgery 79(2):194–203
Neary WJ, Hillier VF, Flute T, Stephens D, Ramsden RT, Evans DGR (2010) Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2. J Laryngol Otol 124:720–728
Neff BA, Wiet RM, Lasak JM, Cohen NL, Pillsbury HC, Ramsden RT, Welling DB (2007) Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 117(6):1069–1072
Odat HA, Piccirillo E, Sequino G, Taibah A, Sanna M (2011) Management strategy of vestibular schwannoma in neurofibromatosis type 2. Otol Neurotol 32:1163–1170
Pan HC, Sheehan J, Sheu ML, Chiu WT, Yang DY (2012) Intracapsular decompression or radical resection followed by Gamma Knife surgery for patients harboring a large vestibular schwannoma. J Neurosurg 117(suppl):69–77
Peng KA, Chen BS, Lorenz MB et al (2018) Revision surgery for vestibular schwannomas. J Neurol Surg B Skull Base 79(6):528–532
Régis J, Roche PH, Delsanti C, Thomassin JM, Ouaknine M, Gabert K, Pellet W (2007) Modern management of vestibular schwannomas. Prog Neurol Surg 20:129–141
Roehm PC, Mallen-St Clair J et al (2011) Auditory rehabilitation of patients with neurofibromatosis type 2 by using cochlear implants. J Neurosurg 115(4):827–834
Schwartz MS, Otto SR, Shannon RV, Hitselberger WE, Brackmann DE (2008) Auditory brainstem implants. Neurotherapeutics 5(1):128–136
Spatola G, Carron R, Delsanti C, Thomassin JM, Roche PH, Régis J (2016) Long-term results of Gamma-knife stereotactic radiosurgery for vestibular schwannomas in patients with type 2 neurofibromatosis. Neurochirurgie DOI 64:355–363. https://doi.org/10.1016/j.neuchi.2016.03.005
Sun S, Liu A (2014) Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis type 2. J Neurosurg 121(suppl):143–149
Ba T, Huy P, Kania R, Frachet B, Poncet C, Legac MS (2009) Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2. Acta Otolaryngol 129:971–975
Troude L, Boucekine M, Montava M, Lavieille JP, Régis J, Roche PH (2018) Adjunctive Gamma-Knife Surgery or Wait & Scan policy after optimal resection of large vestibular schwannomas: clinical and radiological outcomes. World Neurosurgery DOI 118:e895–e905. https://doi.org/10.1016/j.wneu.2018.07.093
Tysome JR, Macfarlane R, Durie-Gair J, Donnelly N, Mannion R, Knight R, Harris F, Vanat ZH, Tam YC, Burton K, Hensiek A, Raymond FL, Moffat DA, Axon PR (2012) Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2. Otol Neurotol 33:466–472
Van de Langenberg R, de Bondt BJ, Nelemans PJ et al (2009) Follow-up assessment of vestibular schwannomas: volume quantification versus two-dimensional measurements. Neuroradiology 51:517–524
Van de Langenberg R, Hanssens PE, Van Overbeeke JJ et al (2011) Management of large vestibular schwannoma. Part I. Planned subtotal resection followed by Gamma Knife surgery: radiological and clinical aspects. J Neurosurg 115:875–884
Zhao F, Wang B, Yang Z, Zhou Q, Li P, Wang X, Zhang J, Zhang J, Liu P (2018) Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation. J Neuro-Oncol 138(2):417–424
Evans DGR, Baser ME, O’Reilly B et al (2005) Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 19:5–12
Author information
Authors and Affiliations
Contributions
All authors have made substantial contributions so as to qualify for authorship, and have read and approved the final version of this manuscript.
Corresponding author
Ethics declarations
Ethical approval
Ethics approval was obtained from the Comité d’Ethique de l’université d’Aix-Marseille, authorization number: 2018-24-01-003.
Informed consent
Informed consent of all patients was obtained, and our institutional local ethical committee approved this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Submission statement
This manuscript has not been previously published in whole or in part or submitted elsewhere for review.
Rights and permissions
About this article
Cite this article
Troude, L., Boucekine, M., Montava, M. et al. Does NF2 status impact the results of combined surgery and adjunctive Gamma Knife surgery for large vestibular schwannomas?. Neurosurg Rev 43, 1191–1199 (2020). https://doi.org/10.1007/s10143-019-01143-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-019-01143-y